Trial Profile
A Phase 1, Double Blind, Randomized, Placebo Controlled, Parallel Design Pharmacokinetic Drug Interaction Study of ACH-0143102 and ACH-0142684 in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Deldeprevir (Primary) ; Odalasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors Achillion Pharmaceuticals
- 17 Jul 2014 According to the Australian New Zealand Clinical Trials Registry record, status changed from not yet recruiting to completed.
- 06 Mar 2014 As per Australian New Zealand Clinical Trials Registry record planned initiation date changed from 1 Mar 2014 to 3 Feb 2014.
- 06 Mar 2014 As per Australian New Zealand Clinical Trials Registry record trials status changed from planning to not yet recruiting.